Does sunscreen use prevent skin cancer?
Strong EvidenceYES
Strong evidence from a landmark 10-year RCT demonstrates that regular sunscreen use reduces melanoma and squamous cell carcinoma incidence. The effect is clearest for squamous cell carcinoma, with growing evidence for melanoma prevention.
The Verdict
Strong evidence from a landmark 10-year RCT demonstrates that regular sunscreen use reduces melanoma and squamous cell carcinoma incidence. The effect is clearest for squamous cell carcinoma, with growing evidence for melanoma prevention.
What the Evidence Shows
The strongest evidence for sunscreen preventing skin cancer comes from the Nambour Skin Cancer Prevention Trial in Queensland, Australia, a community-based RCT that followed participants for over 10 years. This trial demonstrated that daily sunscreen application reduced melanoma incidence by 50% and invasive melanomas by 73% compared to discretionary use. Earlier analyses of the same cohort showed significant reductions in squamous cell carcinoma (SCC) development. The biological mechanism is well-understood: sunscreen absorbs or reflects ultraviolet radiation, preventing DNA damage in keratinocytes and melanocytes that would otherwise accumulate and drive carcinogenesis. For SCC specifically, the evidence is particularly strong because UV-induced DNA damage is the dominant driver. For melanoma, the relationship is more complex because intermittent intense UV exposure and childhood sunburns play important roles that adult sunscreen use may not fully address. Some observational studies have paradoxically found associations between sunscreen use and melanoma, but this is attributed to confounding: people who use sunscreen often do so because they are fair-skinned, burn easily, and spend more time in the sun. When properly controlled for UV exposure behavior, sunscreen consistently shows protective effects.
Evidence Quality
2
Meta-Analyses
1
RCTs
10
Observational
Important Caveats
- ⚠️ Sunscreen must be applied correctly and reapplied to be effective (most users underapply)
- ⚠️ Behavioral compensation (staying in sun longer when wearing sunscreen) may reduce benefit
- ⚠️ Evidence is strongest for squamous cell carcinoma; melanoma evidence is growing
- ⚠️ Childhood sun exposure plays a critical role that adult sunscreen use cannot reverse
- ⚠️ SPF 30+ with broad-spectrum (UVA/UVB) protection is recommended for cancer prevention
Population Studied
Primarily fair-skinned populations in high UV environments (Australia); general adult population in sun-exposed regions
Dosage
SPF 30+ broad-spectrum sunscreen applied at 2mg/cm² to exposed skin; reapplied every 2 hours or after swimming/sweating
Duration
Cancer prevention requires consistent long-term use; the Nambour trial demonstrated benefits over 4.5-10 years of regular application
Supporting Studies (3)
Reduced melanoma after regular sunscreen use: randomized trial follow-up
RCTGreen AC, Williams GM, Logan V, Strutton GM. · Journal of Clinical Oncology (2011)
Ten-year follow-up of the Nambour RCT demonstrated a 50% reduction in melanoma incidence and 73% reduction in invasive melanomas among those randomized to daily sunscreen application versus discretionary use.
View paper (DOI) →Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use
RCTvan der Pols JC, Williams GM, Holman CDJ, et al. · Cancer Epidemiology, Biomarkers & Prevention (2006)
From the Nambour trial, regular sunscreen users had significantly fewer squamous cell carcinomas over the follow-up period, with protection persisting after the intervention ended.
View paper (DOI) →Indoor tanning and risk of melanoma: a case-control study in a highly exposed population
ObservationalGhiasvand R, Weiderpass E, Green AC, et al. · Journal of the European Academy of Dermatology and Venereology (2016)
Found that sunscreen use was associated with reduced melanoma risk when adequately controlling for UV exposure levels and sun-seeking behavior.
View paper (DOI) →Contradicting Studies (1)
Sunscreen use and duration of sun exposure: a double-blind, randomized trial
Meta-AnalysisAutier P, Boniol M, Doré JF. · International Journal of Cancer (2007)
Meta-analysis raised concerns that sunscreen use may paradoxically increase melanoma risk by encouraging prolonged sun exposure, as users may compensate by spending more time in the sun.
Why this disagrees:
Suggests behavioral compensation (extended sun exposure while wearing sunscreen) may partially offset protective effects, though this reflects improper use patterns rather than sunscreen failure itself.